A de novo splice donor mutation in the thrombopoietin gene causes hereditary thrombocythemia in a Polish family

Abstract

A mutation in THPO occurred de novo in the same position as in a previously described family with hereditary thrombocythemia. Patients with this mutation have elevated serum levels of thrombopoietin and a phenotype that responds to aspirin and does not require cytoreductive treatment.